Baudax Bio, Inc. Profile Avatar - Palmy Investing

Baudax Bio, Inc.

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-N…

Biotechnology
US, Malvern [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of BXRX's Analysis
CIK: 1780097 CUSIP: 07160F206 ISIN: US07160F4046 LEI: - UEI: -
Secondary Listings
BXRX has no secondary listings inside our databases.